Revelation Biosciences
REVB
6 hedge funds and large institutions have $13.3K invested in Revelation Biosciences in 2025 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, reducing their positions, and 4 closing their positions.
0.07% more ownership
Funds ownership: 0.01% → 0.08% (+0.07%)
25% less funds holding
Funds holding: 8 → 6 (-2)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
73% less capital invested
Capital invested by funds: $49.4K → $13.3K (-$36.1K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IA
IFP Advisors
Tampa,
Florida
|
+$19.8K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$8.77K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$6.25K |
| 4 |
SS
SBI Securities
Tokyo,
Japan
|
+$2.35K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$1.62K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$23K |
| 2 |
TSS
Two Sigma Securities
New York
|
-$13.4K |
| 3 |
SG
StoneX Group
New York
|
-$6.52K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$5.05K |
| 5 |
Morgan Stanley
New York
|
-$3 |
REVB Hedge Fund Activity: Q1 2025 in Review
6 of the 7,461 institutional investors tracked by Wall St. Rank reported a position in Revelation Biosciences (REVB) for Q1 2025, worth a combined $13.3K — down 73% from $49.4K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of REVB and 2 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 4 added.
The largest buyer was IFP Advisors, opening a new position worth an estimated $19.8K. The largest seller was XTX Topco, exiting entirely with an estimated $23K sold.
- 6 institutional investors held Revelation Biosciences (REVB) as of Q1 2025, down from 8 in Q4 2024.
- Funds reported $13.3K of Revelation Biosciences stock for Q1 2025, down 73% quarter-over-quarter.
- 2 funds opened new Revelation Biosciences positions in Q1 2025 and 4 closed out, a net change of -2 holders.
- The largest Revelation Biosciences buyer in Q1 2025 was IFP Advisors, an estimated $19.8K added.
- The largest Revelation Biosciences seller in Q1 2025 was XTX Topco, an estimated $23K sold.
Based on aggregated 13F filings for Q1 2025.